FDA planning new guidelines Jan 15 2019 The FDA plans to hire at least 50 new clinical reviewers tasked with cell and gene therapy to prepare for what the agency describes as a surge of cutting edge products currently entering early development ..FDA commishnor Scott Gottlieb said we anticipate that by 2020 we will be receiving more than 200 IND,s per year building on more than 800 currently active cell based or directly administered gene therapy IND,s currently on file with the FDA ....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
0.620(34.6%) |
Mkt cap ! $3.084B | |||
| Open | High | Low | Value | Volume |
| $1.90 | $2.48 | $1.90 | $58.82M | 25.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 100915 | $2.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.41 | 99 | 1 |
View Market Depth
| Last trade - 16.12pm 18/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |